Trade terms tipped to slow PBS approvals

The industry has responded to US President Trump’s 100% tariff on pharmaceuticals and other trade policy threats, outlining the likely impacts – and exemptions The US president’s decision to slap a 100% tariff on pharmaceutical imports is expected to hurt newer, innovative medicines-makers, but is unlikely to majorly hurt our biggest pharma exporter. That’s the